P B F
1 Fev, 2022

Genetic Testing for Diagnosis and Management of Mental Health Conditions

Effective 1 de abril, 2022, the criteria used for medical necessity review of GeneSight Psychotropic panel for Medicare Advantage plans will be updated. Please refer to the draft medical policy for details here.